Cargando…

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB

Detalles Bibliográficos
Autores principales:	Petruccioli, E., Farroni, C., Cuzzi, G., Vanini, V., Palmieri, F., Vittozzi, P., Goletti, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2022
Materias:	Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734189/ https://www.ncbi.nlm.nih.gov/pubmed/34969431 http://dx.doi.org/10.5588/ijtld.21.0478

Ejemplares similares

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
por: Zokufa, N., et al.
Publicado: (2021)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

What Research Is Needed to Stop TB? Introducing the TB Research Movement
por: Lienhardt, Christian, et al.
Publicado: (2011)

A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab
por: Xiao, Yue, et al.
Publicado: (2023)

First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting
por: Aziz, Zirwatul Adilah, et al.
Publicado: (2023)

Hierarchy Low CD4+/CD8+ T-Cell Counts and IFN-γ Responses in HIV-1+ Individuals Correlate with Active TB and/or M.tb Co-Infection
por: Shao, Lingyun, et al.
Publicado: (2016)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Coordinated In Vitro Release of Granulysin, Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment
por: Pitabut, Nada, et al.
Publicado: (2020)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Towards quality adolescent-friendly services in TB care
por: Laycock, K. M., et al.
Publicado: (2021)

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Criminal Justice Reform as HIV and TB Prevention in African Prisons
por: Todrys, Katherine W., et al.
Publicado: (2012)

Active case-finding for TB among incarcerated women in Peru
por: Puma, D., et al.
Publicado: (2023)

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
por: Mohr-Holland, E., et al.
Publicado: (2021)

Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6
por: Ruhwald, Morten, et al.
Publicado: (2017)

Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy
por: Torre, Alessandro, et al.
Publicado: (2020)

Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals
por: Broderick, Claire, et al.
Publicado: (2021)

Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn’s disease in patients with positive results
por: Zhao, Yujie, et al.
Publicado: (2020)

Striking the Right Balance Determines TB or Not TB
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
por: Kaplan, Richard, et al.
Publicado: (2018)

Tim-3-Expressing CD4(+) and CD8(+) T Cells in Human Tuberculosis (TB) Exhibit Polarized Effector Memory Phenotypes and Stronger Anti-TB Effector Functions
por: Qiu, Yueqin, et al.
Publicado: (2012)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Comparison of IFN-γ Levels in Children with Tuberculosis Disease (TB) and Latent Tuberculosis Infection (LTBI)
por: Boskovska, Katerina, et al.
Publicado: (2018)

The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China
por: Chen, Cheng, et al.
Publicado: (2023)

A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multicentric Study (2006–2008). Evaluation of QuantiFERON-TB Gold in Tube for TB Diagnosis
por: Lagrange, Philippe H., et al.
Publicado: (2013)

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)

High prevalence of TB disease in contacts of adults with extrapulmonary TB
por: Wingfield, Tom, et al.
Publicado: (2018)

Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana
por: Ansa, Gloria Akosua, et al.
Publicado: (2012)

Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
por: Jarde, Alexander, et al.
Publicado: (2022)

TB granuloma: CD30 co-stimulation for CD4(+) T cell co-operation
por: Gress, Abigail R., et al.
Publicado: (2023)

Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection
por: Wang, Linchuan, et al.
Publicado: (2018)

CLINICAL APPLICATION OF RT-PCR IN TUBERCULOSIS DNA DETECTION COMBINED WITH TB-IGRA IN THE DIAGNOSIS OF SPUTUM SMEAR-NEGATIVE PULMONARY TUBERCULOSIS
por: Chen, Gao, et al.
Publicado: (2022)

Finding gaps in TB notifications: spatial analysis of geographical patterns of TB notifications, associations with TB program efforts and social determinants of TB risk in Bangladesh, Nepal and Pakistan
por: van Gurp, Margo, et al.
Publicado: (2020)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
por: Grace, Patricia S., et al.
Publicado: (2021)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iapeie8d26eieuk571k0bi8fgd